These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Immunological studies on monovalent and bivalent Cerastes antivenin. Mohamed AH; Abdel-Baset A; Hassan A Toxicon; 1980; 18(3):384-7. PubMed ID: 6771891 [No Abstract] [Full Text] [Related]
25. Cross-neutralisation of Australian brown snake, taipan and death adder venoms by monovalent antibodies. Isbister GK; O'Leary MA; Hagan J; Nichols K; Jacoby T; Davern K; Hodgson WC; Schneider JJ Vaccine; 2010 Jan; 28(3):798-802. PubMed ID: 19879227 [TBL] [Abstract][Full Text] [Related]
26. The production and control of anti--venous sera. Bolaños R; Cerdas L Dev Biol Stand; 1978; 41():109-16. PubMed ID: 89053 [TBL] [Abstract][Full Text] [Related]
27. [The antigenicity of toxic proteins from the venoms of Elapidae and Hydrophiidae]. Boquet P; Dumarey C; Joseph D C R Acad Hebd Seances Acad Sci D; 1977 Jun; 284(23):2439-42. PubMed ID: 409524 [No Abstract] [Full Text] [Related]
28. Venomous snakebites. Current concepts in diagnosis, treatment, and management. Gold BS; Barish RA Emerg Med Clin North Am; 1992 May; 10(2):249-67. PubMed ID: 1559468 [TBL] [Abstract][Full Text] [Related]
29. Endogenous thrombin potential as a novel method for the characterization of procoagulant snake venoms and the efficacy of antivenom. Isbister GK; Woods D; Alley S; O'Leary MA; Seldon M; Lincz LF Toxicon; 2010 Aug; 56(1):75-85. PubMed ID: 20338189 [TBL] [Abstract][Full Text] [Related]
30. A pilot experiment for production of Malayan krait antivenom: immunization of rabbits with Bungarus candidus venom. Chanhome L; Puempunpanich S; Omori-Satoh T; Chaiyabutr N; Sitprija V J Nat Toxins; 2002 Dec; 11(4):353-6. PubMed ID: 12503879 [TBL] [Abstract][Full Text] [Related]
31. Survey of assay methods of antivenins; immunological factors influencing antivenin standardization. GRASSET E Bull World Health Organ; 1957; 16(1):79-122. PubMed ID: 13413648 [TBL] [Abstract][Full Text] [Related]
32. Clinical laboratory: enzyme immunoassay for the rapid clinical identification of snake venom. Coulter AR; Harris RD; Sutherland SK Med J Aust; 1980 May; 1(9):433-5. PubMed ID: 6993892 [TBL] [Abstract][Full Text] [Related]
33. [Exotic snake bites in Switzerland]. Stadelmann M; Ionescu M; Chilcott M; Berney JL; Gétaz L Rev Med Suisse; 2010 May; 6(248):969-72. PubMed ID: 20545262 [TBL] [Abstract][Full Text] [Related]
35. Coagulant and anticoagulant actions of Australian snake venoms. Marshall LR; Herrmann RP Thromb Haemost; 1983 Oct; 50(3):707-11. PubMed ID: 6648891 [TBL] [Abstract][Full Text] [Related]
36. [Production and control of antivenin sera in Costa Rica]. Bolaños R; Cerdas L Bol Oficina Sanit Panam; 1980 Mar; 88(3):189-96. PubMed ID: 6449932 [No Abstract] [Full Text] [Related]
37. Characterization of a new polyvalent antivenom (Antivipmyn Africa) against African vipers and elapids. Ramos-Cerrillo B; de Roodt AR; Chippaux JP; Olguín L; Casasola A; Guzmán G; Paniagua-Solís J; Alagón A; Stock RP Toxicon; 2008 Dec; 52(8):881-8. PubMed ID: 18926842 [TBL] [Abstract][Full Text] [Related]
38. Molecular immunology of snake toxins. Ménez A Pharmacol Ther; 1985; 30(1):91-113. PubMed ID: 2944134 [No Abstract] [Full Text] [Related]
39. Management of snakebite. Johnson CA Am Fam Physician; 1991 Jul; 44(1):174-80. PubMed ID: 2058530 [TBL] [Abstract][Full Text] [Related]
40. Efficacy of low-dose snake antivenom in severe neurotoxic snake envenoming. Singh A; Agarwal R Am J Emerg Med; 2008 Nov; 26(9):1058-9. PubMed ID: 19091272 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]